Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

World TB Day – Our Top 6 Articles on Tuberculosis

by Global Biodefense Staff
March 24, 2013

As we mark this year’s annual awareness day for tuberculosis—the second greatest killer worldwide due to a single infectious agent—we reflect on our recent coverage of science and policy efforts to improve TB prevention and control.

1. Latent tuberculosis hides out in bone marrow stem cells   Scientists at the Forsyth Institute have gained new insight on how Tuberculosis (TB) remains a global epidemic. Although drugs have been available to fight TB for decades, the disease still infects nearly 2.2 billion people worldwide and causes 1.7 million annual deaths. This is largely attributed to the bacteria’s ability to stay dormant in the human body and later resurface as active disease.

2. The ingenious defense mechanism of tuberculosis bacterium   Biologists lead by Joris Messens of the Vrije Universiteit Brussel in Belgium have discovered that the bacterium that causes tuberculosis, Mycobacterium tuberculosis, has an unique defense mechanism against oxygen. 

3. FDA grants priority review for multi-drug resistant tuberculosis treatment   Janssen Research & Development (Janssen) yesterday announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for bedaquiline (TMC207) to treat pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults as part of combination therapy.

4. Top pharma and research institutes partner for ‘TB drug accelerator’   A groundbreaking collaborative between drug makers and research institutions seeks to leverage collective abilities to speed up the discovery of essential new treatments for tuberculosis (TB).

5. Tracing TB outbreaks: whole genome sequencing better than standard test   A new form of genetic testing of the bacteria that causes tuberculosis can provide better information on TB transmission and also trace TB outbreaks more accurately than the current standard test, according to a study from Germany published in this week’s PLOS Medicine.

6. UC Davis develops new latent TB testing method   Engineers at UC Davis have developed a microfluidic chip to test for latent tuberculosis (TB) which aims to be more reliable, faster and less expensive than current testing options available.

Read more about World TB Day at the WHO website: Director-General’s message on World TB Day

Tags: Tuberculosis

Related Posts

Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC